Chemical-structure (A0bd00e9 9813 4ea7 B640 1eb59202751b 01)
Atorvastatin Calcium
Product Images NDC 66116-498
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 66116-498). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Medvantx, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure-01 (A0bd00e9 9813 4ea7 B640 1eb59202751b 02)
Figure-02 (A0bd00e9 9813 4ea7 B640 1eb59202751b 03)
The text seems to show a Cumulative Hazard graph with percentages and time in years on the x-axis. Atorvastatin is mentioned on the y-axis with some HR values. Unfortunately, there is not enough information to obtain a useful description.*
Figure-03 (A0bd00e9 9813 4ea7 B640 1eb59202751b 04)
This text appears to be a report or an analysis in a scientific or medical study involving two different medications - Horvastatin and Sorvastatin. The report provides the percentage of subjects experiencing E vert (which is unclear without additional context) after taking the medications. Additionally, it appears that the study also evaluated the time to the first major cardiovascular endpoint for each medication. The results show a hazard ratio of 0.78 for Horvastatin, which suggests a lower risk compared to Sorvastatin.*
Atorvastatin 20mg Tablets #30 (A0bd00e9 9813 4ea7 B640 1eb59202751b 05)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
